CLINICAL COURSE AND DISEASE OUTCOME IN COVID-19 PATIENTS WITH DIABETES MELLITUS

  • Rusmir Baljic Clinic for infectious diseases, Clinical center University of Sarajevo, Bosnia and Herzegovina.
  • Ahmed Velic Clinic for infectious diseases, Clinical center University of Sarajevo, Bosnia and Herzegovina.
  • Amila Muhic Clinic for infectious diseases, Clinical center University of Sarajevo, Bosnia and Herzegovina.
  • Refet Gojak Clinic for infectious diseases, Clinical center University of Sarajevo, Bosnia and Herzegovina.
  • Belma Gazibera Clinic for infectious diseases, Clinical center University of Sarajevo, Bosnia and Herzegovina.
  • Nermina Bajramovic Clinic for infectious diseases, Clinical center University of Sarajevo, Bosnia and Herzegovina.
  • Meliha Hadzovic– Cengic Clinic for infectious diseases, Clinical center University of Sarajevo, Bosnia and Herzegovina.
  • Ilhama Huric Clinic for infectious diseases, Clinical center University of Sarajevo, Bosnia and Herzegovina.
10.22270/ujpr.v6i2.567

Keywords:

Outcome, COVID-19, Diabetes mellitus

Abstract

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19) whose pandemic was declared on March 11 2021 (1). Spectrum of COVID-19 clinical manifestations is very wide. Most patients report to ambulance with mild or moderate symptoms, but some of them rapidly develops acute respiratory distress syndrome (ARDS), respiratory failure, acute cardiac injury, multiple organ failure and death (2). Older age, diabetes mellitus and cardiovascular disease are reported as high predictors of morbidity and mortality.

Aim: To determine correlation between diabetes mellitus and severity of clinical picture in patients with COVID-19.

Methods: Current study involve retrospective analysis of 1513 patients with Real Time PCR confirmed COVID-19 hospitalized in Clinic for infectious disease, University Clinical Center, Sarajevo, Bosnia and Herzegovina, in a period of June 2020 to December 2020.

Results: Among them 417 had previously diagnosed of diabetes mellitus. Results show that patients with diabetes mellitus are likely to require treatment in Intensive care unit, and oxygenic support with invasive ventilation. There was no statistically significant difference in outcome of the disease.

Conclusion: Even this study didn’t find increased mortality in patients with COVID-19 and diabetes mellitus, further studies should be done to determine risk for patients with DM to develop severe form of disease.

                  r65.gif

Peer Review History:

Received 5 February 2021; Revised 9 March; Accepted 12 April; Available online 15 May 2021

Academic Editor: Prof. Dr. Gorkem Dulgerorcid22.jpg, Duzce University, Turkey, gorkemdulger@yandex.com

Received file:blue_23983.gif                Reviewer's Comments:download_logo_r_29189.gif

Average Peer review marks at initial stage: 6.0/10

Average Peer review marks at publication stage: 7.5/10

Reviewer(s) detail:

Dr. Branislav Rankovićorcid22.jpg, University of Kragujevac, Serbia, rankovic@kg.ac.rs

Dr. Poualeu  Kamani  Sylviane  Laureorcid22.jpg, University of Dschang, Cameroon, poualeusylviane@yahoo.fr

Downloads

Download data is not yet available.
Crossmark
Statistics
339 Views | 189 Downloads
Dimension Citations

Published

2021-05-15

How to Cite

Baljic, R., A. Velic, A. Muhic, R. Gojak, B. Gazibera, N. Bajramovic, M. Hadzovic– Cengic, and I. Huric. “CLINICAL COURSE AND DISEASE OUTCOME IN COVID-19 PATIENTS WITH DIABETES MELLITUS”. Universal Journal of Pharmaceutical Research, vol. 6, no. 2, May 2021, doi:10.22270/ujpr.v6i2.567.

Issue

Section

Research Articles
Share |

Similar Articles

You may also start an advanced similarity search for this article.